A 50-year-old lady is started on adalimumab after not responding to conventional DMARDs for her rheumatoid arthritis. | Medibuddy
25th February 2025

A 50-year-old lady is started on adalimumab after not responding to conventional DMARDs for her rheumatoid arthritis.

A 50-year-old lady is started on adalimumab after not responding to conventional DMARDs for her rheumatoid arthritis. Which type of cancer risk is important to warn her about with this type of drug?

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.